Alvotech Future Growth
Future criteria checks 5/6
Alvotech is forecast to grow earnings and revenue by 95.2% and 43.1% per annum respectively while EPS is expected to grow by 96.9% per annum.
Key information
95.2%
Earnings growth rate
96.9%
EPS growth rate
| Biotechs earnings growth | 21.2% |
| Revenue growth rate | 43.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03
Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically
Sep 03Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump
May 05Shareholders Shouldn’t Be Too Comfortable With Alvotech's (NASDAQ:ALVO) Strong Earnings
Nov 23Fuji Pharma files for approval of biosimilar candidate in Japan
Oct 17Alvotech and STADA launch Humira biosimilar in Switzerland
Sep 22Alvotech GAAP EPS of -$1.02, revenue of $40.1M
Aug 31Alvotech starts pharmacokinetic study for its biosimilar to Amgen's bone disease drugs
Jul 20Icelandic biosimilars developer Alvotech initiated with a hold rating by Deutsche Bank
Jul 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 870 | 180 | 372 | 372 | 2 |
| 12/31/2025 | 606 | 30 | 203 | 203 | 5 |
| 12/31/2024 | 321 | -149 | 49 | 49 | 3 |
| 12/31/2023 | 93 | -552 | -359 | -312 | N/A |
| 9/30/2023 | 64 | -596 | -356 | -309 | N/A |
| 6/30/2023 | 65 | -416 | -347 | -299 | N/A |
| 3/31/2023 | 100 | -713 | -411 | -361 | N/A |
| 12/31/2022 | 85 | -514 | -361 | -312 | N/A |
| 9/30/2022 | 96 | 61 | -388 | -319 | N/A |
| 6/30/2022 | 78 | -12 | -345 | -285 | N/A |
| 3/31/2022 | 39 | -42 | -274 | -223 | N/A |
| 12/31/2021 | 40 | -102 | -269 | -228 | N/A |
| 12/31/2020 | 69 | -170 | -86 | -74 | N/A |
| 12/31/2019 | 83 | -210 | -97 | -89 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALVO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: ALVO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALVO is expected to become profitable in the next 3 years.
Revenue vs Market: ALVO's revenue (43.1% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: ALVO's revenue (43.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALVO's Return on Equity is forecast to be high in 3 years time